Titre : Triple combination cures most hepatitis C patients with prior DAA treatment failure
link : Triple combination cures most hepatitis C patients with prior DAA treatment failure
Triple combination cures most hepatitis C patients with prior DAA treatment failure
Triple combination cures most hepatitis C patients with prior DAA treatment failure
Liz Highleyman
Produced in collaboration with hivandhepatitis.com
Published: 28 April 2017
Liz Highleyman
Produced in collaboration with hivandhepatitis.com
Published: 28 April 2017
Almost all people with genotype 1 hepatitis C who were previously unsuccessfully treated with a course of interferon-free direct-acting antiviral therapy achieved sustained response when retreated with a three-drug combination being developed by Merck, researchers reported at the International Liver Congress last week in Amsterdam.
Direct-acting antivirals (DAAs) have revolutionised the treatment of chronic hepatitis C virus (HCV) infection, with cure rates approaching 100% for most groups of patients. But better options are still needed for people who do not respond to a first attempt at interferon-free therapy and may have drug-resistant virus.
Continue reading...
Meeting Updates
Updates On This Blog
Hep C 5-minute videos - Summary Of The International Liver Congress™ (ILC) 2017
NAM aidsmap
Clinical Care Options
HIV and Hepatitis
Hep
Direct-acting antivirals (DAAs) have revolutionised the treatment of chronic hepatitis C virus (HCV) infection, with cure rates approaching 100% for most groups of patients. But better options are still needed for people who do not respond to a first attempt at interferon-free therapy and may have drug-resistant virus.
Continue reading...
Meeting Updates
Updates On This Blog
Hep C 5-minute videos - Summary Of The International Liver Congress™ (ILC) 2017
On this page of the blog visitors are provided with an index of links pointing to comprehensive coverage of the meeting. Start by viewing a short video series over at Practice Point presented by Dr. Tran, highlights include clinical studies on new antiviral therapy, data on drug toxicity/adverse events, drug interactions, and strategies for HCV management. On May 1, ViralEd will launch: The Advances in Chronic Hepatitis C: Management and Treatment, a comprehensive program featuring HCV experts reviewing and discussing the most important studies on chronic hepatitis C presented at EASL 2017. Other videos include EASL press conference, and opening ceremony.
Coverage
infohepNAM aidsmap
Clinical Care Options
HIV and Hepatitis
Hep
Thus articles Triple combination cures most hepatitis C patients with prior DAA treatment failure
that is all articles Triple combination cures most hepatitis C patients with prior DAA treatment failure This time, hopefully can provide benefits to you all. Okay, see you in another article post.
You are now reading the article Triple combination cures most hepatitis C patients with prior DAA treatment failure the link address https://newsaninpiration.blogspot.com/2017/04/triple-combination-cures-most-hepatitis.html
0 Response to "Triple combination cures most hepatitis C patients with prior DAA treatment failure"
Post a Comment